TMS Co., Ltd.

¥131.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4891Healthcare
Country Japan
PE (Fwd) •••
TSR 4Y CAGR (36.70%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.35
PE TTM —
TSR TTM (7.75%)
Mkt cap ¥5.982B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥159
21.27%
208.62%
Hold 7|11|6|10|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
2.57
2.75
2.75
2.79
20.48%
26.21%
18.32%
11.97%
Revenue¥M
665.2
651.4
642.6
632.1
10.84%
10.37%
6.91%
0.22%
Peers (US$37.98M)
Cap (US$)
PE
38.31M
—
38.07M
—
Capital
TTM
5Y
10Y
Leveragex
1.208
0.541
0.535
EBIT/Intx
2.743
0.508
0.439
Own earn%
(18.36)
(72.58)
(71.56)
Sh yield%
44.50
59.83
59.13
Owners
Insiders/Inst%
8.53
30.26
Short interest%
3.87
SBC / revenue%
2.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
2–8
$1 testx
0.6
Incr. ROIC%
4